Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Various cytoskeletal proteins have been implicated in the cellular pathology of Alzheimer's disease. A monoclonal antibody (SMI32) that recognizes nonphosphorylated epitopes on the medium (168 kDa) and heavy (200 kDa) subunits of neurofilament proteins has been used to label and analyze a specific subpopulation of pyramidal neurons in the prefrontal and inferior temporal cortices of normal and Alzheimer's disease brains. In Alzheimer's disease, the distribution of neuropathological markers predominates in layers III and V in these association areas. In these neocortical regions, SMI32 primarily labels the perikarya and dendrites of large pyramidal neurons, predominantly located within layers III and V. In Alzheimer's disease, a dramatic loss of SMI32-immunoreactive (ir) cells was observed, affecting particularly the largest cells (i.e., cells with a cross-sectional perikaryal area larger than 350 microns 2). The staining intensity of the largest SMI32-ir neurons was significantly reduced in Alzheimer's disease cases, suggesting that an inappropriate phosphorylation of these cytoskeletal proteins may take place in the course of the pathological process. In addition, the SMI32-ir neuron loss and total neuron loss were highly correlated with neurofibrillary tangle counts, whereas such a correlation was not observed with neuritic plaque counts. These quantitative data suggest that SMI32-ir neurons represent a small subset of pyramidal cells that share certain anatomical and molecular characteristics and are highly vulnerable in Alzheimer's disease. Other studies have suggested that SMI32-ir neurons are likely to furnish long corticocortical projections. Thus, their loss would substantially diminish the effectiveness of the distributed processing capacity of the neocortex, resulting in a neocortical isolation syndrome as reflected by the clinical symptomatology observed in these patients. Such correlations between the expression of a selective cellular pathology and specific elements of cortical circuitry will increase our understanding of the molecular and cellular characteristics underlying a given neuronal subclass vulnerability in Alzheimer's disease or other neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neuron loss is a basic and fundamental feature in the pathogenesis of AD [18,19], starting already at preclinical stages when the neuropathological hallmarks are not yet present [20].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [19]
In the citing paper
“For example, there was a selective loss of excitatory neurons in the supragranular layers (L2/3 IT)9,54.”
From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [54]
In the citing paper
“In humans, neurons in the prefrontal cortex with specialization such as these exhibit enhanced susceptibility to neurodegeneration in the course of disorders like Alzheimer’s disease (31–34).”
From Evolution of increased glia–neuron ratios in the human frontal cortex (2006) · cites this paper as [33]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Circuitry of Primate Prefrontal Cortex and Regulation of Behavior by Representational Memory
Goldman‐Rakic, P. S. (1987) · Comprehensive Physiology · doi:10.1002/cphy.cp010509 · Cited by 1,960
AN ANATOMICAL STUDY OF CONVERGING SENSORY PATHWAYS WITHIN THE CEREBRAL CORTEX OF THE MONKEY
JONES, E. G., & POWELL, T. P. S. (1970) · Brain · doi:10.1093/brain/93.4.793 · Cited by 1,711
Topography of Cognition: Parallel Distributed Networks in Primate Association Cortex
Goldman-Rakic, P. S. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.001033 · Cited by 1,660
Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225
Sternberger, L. A., & Sternberger, N. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6126 · Cited by 1,158
The functional logic of cortical connections
Zeki, S., & Shipp, S. (1988) · Nature · doi:10.1038/335311a0 · Cited by 1,067
Principles of behavioral neurology
Mesulam, M. M. (1985) · Davis eBooks · Cited by 991
Research works printed but not linked: 7
- Campbell M. J., 1989, A subset of primate corticocortical neurons are neurofilament protein (NFP) immunoreactive (ir): a combined retrograde immunohistochemical study, Proc. Soc. Neurosci., 15, 72
- Gambetti P., 1987, Neurochemistry of Aging, 309
- Goldman‐Rakic P. S., 1987, Handbook of Physiology, 373
- Hof P. R., 1988, Quantitative analysis of non‐phosphorylated neurofilament protein (NPNFP)‐immunoreactive neurons in normal and Alzheimer's disease brain, Proc. Soc. Neurosci., 14, 1086
- Morrison J. H., 1986, The Biological Substrates of Alzheimer's Disease, UCLA Forum in Medical Sciences, 115
- Morrison J. H., 1987, Molecular Neuropathology of Aging. Banbury Report, 109
- Rapoport S. I., 1987, Molecular Neuropathology of Aging, Banbury Report, 37
Cited by
Items 301–366 of 366
Costantini, I., Morgan, L., Yang, J., Balbastre, Y., Varadarajan, D., Pesce, L., Scardigli, M., Mazzamuto, G., Gavryusev, V., Castelli, F. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.20.464979 · Cited by 5
Self-citationMcDonald, A. J., & Duque, A. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147767 · Cited by 6
Neuropathological Correlates of Dementia in Alzheimer’s Disease
Masliah, E., & Salmon, D. P. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_15 · Cited by 8
Hof, P. R., Nimchinsky, E. A., Ungerleider, L. G., & Morrison, J. H. (1997) · Springer eBooks · doi:10.1007/978-3-642-60680-9_6 · Cited by 7
Self-citationExcitatory Amino Acids and Neurotoxicity in the Human Neocortex
Vickers, J. C., Huntley, G. W., & Morrison, J. H. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4615-1853-2_6 · Cited by 5
Self-citationMultifocal Cortical Neurodegeneration in Alzheimer’s Disease
Vogt, B. A., Martin, A. D., Vrana, K. E., Absher, J. R., Vogt, L. J., & Hof, P. R. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_16 · Cited by 5
Self-citationHeyer, D. B., Wilbers, R., Galakhova, A. A., Hartsema, E. A., Braak, S., Hunt, S., Verhoog, M. B., Muijtjens, M. L., Mertens, E. J., Idema, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.07.430103 · Cited by 4
August, I., Gagneux, P., Semendeferi, K., & Marchetto, M. C. (2025) · Evolutionary Anthropology Issues News and Reviews · doi:10.1002/evan.22054 · Cited by 6
“SMI ‐ 32 immunoreactive neurons have previously been shown to be selectively vulnerable to degeneration in AD [113, 114].”
Development of prefrontal layer III pyramidal neurons in infants with Down syndrome
Vukšić, M., Petanjek, Z., & Kostović, I. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0027-0 · Cited by 4
Bouras, C., Vallet, P. G., & Hof, P. R. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90055-x · Cited by 4
Self-citationLipovich, L., Hou, Z.-C., Jia, H., Sinkler, C. A., McGowen, M. R., Sterner, K. N., Weckle, A. L., Sugalski, A. B., Pipes, L., Gatti, D. L., et al. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23843 · Cited by 6
“NEFH is a neuronal biomarker of brain injury (Siman et al., 2009) and of neurodegeneration in Alzheimer’s disease (Hof et al., 1990; Bussière et al., 2003a,b; Hof and Morrison, 2004).”
BackgroundSelf-citationZeng, X., Puonti, O., Sayeed, A., Herisse, R., Mora, J., Evancic, K., Varadarajan, D., Balbastre, Y., Costantini, I., Scardigli, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.06.570416 · Cited by 4
“…distinct gene expression alterations, pathology accumulations, and atrophies between these layers in patients with conditions such as schizophrenia [4], autism spectrum disorder [61], and epilepsy [62], Alzheimer’s disease [63, 64, 65], Parkinson’s disease [66], and Huntington’s disease [67].”
BackgroundSelf-citationIntelligence in Multiple Dimensions: Evolutionary Framework for the Study of Human Cognition
Geary, D. C. (2026) · Intelligence & Cognitive Abilities · doi:10.65550/001c.154815 · Cited by 3
Labuza, A., Alldred, M. J., Pidikiti, H., Malek‐Ahmadi, M. H., Lee, S. H., Heguy, A., Coleman, P. D., Chakrabarty, S., Chiosis, G., Mufson, E. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70395 · Cited by 4
Encefalopatia traumática crônica do boxeador (dementia pugilistica)
Areza‐Fegyveres, R., Caramelli, P., & Nitríni, R. (2005) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832005000100003 · Cited by 5
Anatomy of Pathological Alterations in Alzheimer’s Disease
Hyman, B. T. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_13 · Cited by 3
McDonald, A. J., & Mascagni, F. (2021) · The Journal of Comparative Neurology · doi:10.1002/cne.25169 · Cited by 3
“In the human frontal and temporal association cortices SMI-32+ PNs are the neurons most vulnerable to the formation of degenerative neurofibrillary tangles (NFTs) in AD (Hof et al., 1990; Morrison et al., 1987).”
BackgroundInfluentialNeuropathological Changes in Visuospatial Systems in Alzheimer's Disease
von Gunten, A., Giannakopoulos, P., Bouras, C., & Hof, P. R. (2004) · KARGER eBooks · doi:10.1159/000079968 · Cited by 4
Self-citationStudying the Alzheimer's disease brain: Insights, puzzles, and opportunities
Hyman, B. T. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90177-5 · Cited by 4
Cytoarchitectonic gradients of laminar degeneration in behavioral variant frontotemporal dementiaPreprint
Ohm, D. T., Xie, S. X., Capp, N., Arezoumandan, S., Cousins, K. A. Q., Rascovsky, K., Wolk, D. A., Deerlin, V. M. V., Lee, E. B., McMillan, C. T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.05.588259 · Cited by 3
Nixon, R. A., Lee, J., Stavrides, P. H., Darji, S., Goulbourne, C. N., Berg, M. J., Mohan, P. S., Yang, D., Roussos, P., Bleiwas, C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5306901/v1 · Cited by 3
Stanisavljevic, A., Ibrahim, K. W., Stavrides, P. H., Bare, C., Alldred, M. J., Heguy, A., Nixon, R. A., & Ginsberg, S. D. (2025) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2025.110512 · Cited by 2
“…targets in brain tissues in the context of neurodegeneration, particularly in select neuronal populations, such as L3 and L5 pyramidal neurons, which are implicated in disease progression in a number of disorders, including AD dementia (Simic et al., 2014, Dharshini et al., 2021, Hof et al., 1990).”
Regional and Laminar Patterns of Selective Neuronal Vulnerability in Alzheimer's Disease
Hof, P. R. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50011-1 · Cited by 2
Self-citationVingtdeux, V., Buée, L., & Sergeant, N. (2011) · InTech eBooks · doi:10.5772/20567 · Cited by 1
“, 1997) is the question of how does neurofibrillary degeneration is selective toward neuronal subpopulations of cortical brain layers III and V (Hof et al., 1990) and progressively propagates through brain structures.”
BackgroundBiological Transgenic Mouse Models of Alzheimer's Disease
Crews, L. A., Rockenstein, E. M., & Masliah, E. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01227-4 · Cited by 2
“…deafferentation of the limbic system, association neocortex and basal forebrain (Perry et al., 1977; Hyman et al., 1984; Wilcock et al., 1988; Hof et al., 1990; Palmer and Gershon, 1990; Masliah et al., 1993), accompanied by the formation of neuritic plaques, neurofibrillary tangles (NFTs)…”
BackgroundDickstein, D. L., Morrison, J. H., & Hof, P. R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0003 · Cited by 3
Self-citationLarger neuronal size overwhelms maintenance capacity with aging
Dani, S. U. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90102-3 · Cited by 2
Zhao, Z., Cao, Z., Zhu, Q., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3545694/v1 · Cited by 2
Travaglini, K. J., Gabitto, M. I., Ding, Y., Agrawal, A., Postupna, N. O., Mahoney, J. T., Kaplan, E. S., Melief, E. J., Goldy, J., Chakka, A. B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.01.734821 · Cited by 9
Jeong, H., Ren, J., Cheng, W., Volkow, N. D., Ling, H., Zhu, D., Du, C., & Pan, Y. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00530-4 · Cited by 1
“In studies from post-mortem brains of AD patients [78–80] and in transgenic AD rodents [81], early neuropathological changes appear to emerge in the superficial layers (L2-4) before progressing to deeper layers (L5-6).”
Características neuropatológicas y moleculares de la enfermedad de Alzheimer
Rodrigo, J., Martínez, A., Fernández, A. P., Serrano, J., Bentura, M. L., Moreno, E., Aparicio, M., Martínez‐Murillo, R., & Regidor, J. (2007) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(07)73533-3 · Cited by 6
Biological Basis for Cerebral Dysfunction in Schizophrenia in Contrast with Alzheimer’s Disease
Kuljiš, R. O., Colom, L. V., & Rojo, L. E. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00119 · Cited by 1
Genetically Engineered Mouse Models of Neurodegenerative Disorders
Masliah, E., & Crews, L. A. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_19 · Cited by 1
Castro-Mendoza, P. B., Weaver, C. M., Chang, W., Medalla, M., Rockland, K. S., Lowery, L., McDonough, E. M., Varghese, M., Hof, P. R., Meyer, D. E., et al. (2024) · Brain Structure and Function · doi:10.1007/s00429-024-02819-y · Cited by 2
“These two areas are also differentially vulnerable to the effects of normal aging and Alzheimer’s disease in humans, with the DLPFC exhibiting earlier and more severe vulnerability compared to V1 (Braak and Braak 1991; Hof and Morrison 1990; Hof et al. 1990; Grothe et al. 2018; Mrdjen et al. 2019).”
Self-citationVulnerability of neurofilament-expressing neurons in frontotemporal dementia
Daniels, N., Bindoff, A. D., Vickers, J. C., King, A. E., & Collins, J. M. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103974 · Cited by 2
“…a subset of interneurons that have been shown to be resistant to degeneration in AD and to lack immunolabelling for neurofilament triple proteins (Hof et al., 1990; Sampson et al., 1997), unlike other interneurons such as parvalbumin-and calbindin-positive neurons (Thorns et al., 2001; Ruden et…”
BackgroundInfluentialNeuropathology of normal aging in cerebral cortex
Morrison, J. H., Hof, P. R., & Rapp, P. R. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.027 · Cited by 1
Self-citationLACOSTE, M. C. D., & White, C. L. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90022-4 · Cited by 1
Genetically Engineered Models of Human Age-Related Neurodegenerative Diseases
Vickers, J. C. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50027-5 · Cited by 1
Glycosaminoglycans as Potential Future Treatment of Alzheimer's Disease
Cornelli, U. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-661-4_36 · Cited by 1
Búsqueda visual y procesamiento de la información perceptiva en la demencia tipo Alzehimer
Colaço, N. M. R. V. (2009) · Gredos (University of Salamanca) · doi:10.14201/gredos.76572 · Cited by 1
Longevity and Brain Aging: The Paradigm of Centenarians
Bouras, C., Vallet, P. G., Kövari, E., Michel, J., Herrmann, F. R., Hof, P. R., & Giannakopoulos, P. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50010-x
Self-citationNeurobiologic Basis of Age-Related Dementing Disorders
Hof, P. R., Bussière, T., Buxbaum, J. D., & Morrison, J. H. (2006) · Springer eBooks · doi:10.1007/0-387-22621-4_76
Self-citationCerebrospinal fluid biomarkers for differentiating between Alzheimer’s disease and Vascular dementia
Bjerke, M. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)
The Retina in Aging and in Alzheimer's Disease
Kuljiš, R. O. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50036-6
How tight is the connection between synapse loss and clinical dementia?
Kowall, N. W. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00012-4
Winkelmann, E., Lüth, H., Dramm, P., Funk, R. H. W., & Fehrmann, P. (1995) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/s0940-9602(11)80087-7
Brain–specific proteins in Multiple Sclerosis
Petzold, A. (2003) · OpenGrey (Institut de l'Information Scientifique et Technique)
Foster, V. (2015) · Cited by 1
Salminen, L. E. (2016) · IRL - University of Missouri, St. Louis (University of Missouri–St. Louis)
Análisis de la memoria visual y verbal en la demencia tipo Alzheimer leve
Pereira, G. E. P. (2016) · Gredos (University of Salamanca) · doi:10.14201/gredos.132819
Calcium, AMPA/Kainate Receptors, and Selective Neurodegeneration
Weiss, J. H., Yin, H. Z., Carriedo, S. G., & Lu, Y. M. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_42
Zampar, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9004
In Vivo Imaging of Axonal Transport in Aging and Alzheimer’s Disease
Cross, D. J., & Minoshima, S. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_23
Pathophysiology of Brain Aging: A Brief Account on Molecular Changes
Chikkanarayanappa, V., & Gangadharappa, H. (2015) · JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES · doi:10.58739/jcbs/v05i2.11
Baizer, J. S., & Witelson, S. F. (2023) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2023.1069210
Amyloid‐Beta, Tau, and Microglial Activation in Aged Felid Brains
Kulik, V., Edler, M. K., Raghanti, M. A., Imam, A., & Sherwood, C. C. (2024) · The Journal of Comparative Neurology · doi:10.1002/cne.25679 · Cited by 1
“Layer III was a focus because prior research has shown that pyramidal neuronsinneocorticallayersIIIandV,aswellasthehippocampal stratum pyramidale, display extensive neuronal and synaptic loss during AD in humans (Hof, Cox, and Morrison 1990; Scheff and Price 2006).”
Neurological aging and neurodegenerative disease in humans and great apes
Edler, M. K., Hearn, C. J., Guevara, E. E., Mhatre‐Winters, I., Varghese, M., Freire‐Cobo, C., Sherwood, C. C., Richardson, J. R., Raghanti, M. A., & Hof, P. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27380-3.00074-9 · Cited by 1
Self-citationBlatt, G. J., & Kemper, T. L. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_9
NeuroLens: A Holistic Visual Analytics System for Exploring Brain Networks Across Scales
Zhang, W., & Tao, J. (2026) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2026.3701404
“Using the literature query module, the experts found that this potential bio-marker can be linked to several clinical evidences [31], [51].”
Baggiani, M., Giacich, M., Naef, V., Santorelli, F. M., & Damiani, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731096
“This cytoskeletal marker is widely used to assess pyramidal neuron structural integrity and axonal health, and it is known to decrease under conditions of cellular stress and degeneration (Burianová et al., 2015; Hof et al., 1990; Ohm et al., 2025; Petzold, 2005; Voelker, 2004).”
Breevoort, A., Ivanov, D., Horan-Portelance, L., Nana, A. L., Vatsavayai, S. C., Tudoras, À., Wallace, J. L., Ding, J. W., Pereira, F. L., Fernhoff, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.13.738307
When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases
Hunt, J. N., & Kortagere, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06163-6
“Models of tau propagation show that pathology often tracks along anatomical connectivity [85], but residual variance highlights contributions from genetic and cell type–specific factors [86, 87].”
Cytoarchitectural Modules: Functional Specialisation and Disruption in Neuropsychiatric Disorders
Chance, S. A. (2015) · Springer eBooks · doi:10.1007/978-94-017-9900-3_11
“Another group of cortical neurons, usually pyramidal cells, has also been found to be vulnerable in AD: neurons that stain positively for the SMI-32 neurofilament protein (Hof et al. 1990; Morrison et al. 1987).”
Background
Metadata
- Authors
- Hof, P. R., Morrison, J. H., & Cox, K.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of California San Diego (US)
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 1990-11
- Volume
- 301
- Issue
- 1
- Pages
- 44-54
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2049691406
- Cited by
- 365
- References
- 76
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 13 · 2023: 9 · 2022: 8 · 2021: 18 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 10 · 2015: 8 · 2014: 8 · 2013: 4 · 2012: 2
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Comparative Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 05138, P50AG005138, AG-06647)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, pyramidal neurons, neurofilament proteins, neuronal vulnerability, superior frontal cortex, inferior temporal cortex, neurofibrillary tangles, neuronal loss, corticocortical connections
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Antibodies, Monoclonal, Cerebral Cortex, Dendrites, Frontal Lobe, Humans, Immunohistochemistry, Intermediate Filament Proteins, Neurons, Occipital Lobe, Pyramidal Tracts, Temporal Lobe, Neurofilament Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.